SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX)
BCRX 7.385-3.1%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Ian@SI5/14/2008 7:50:47 PM
   of 269
 
BCRX named in Reuters story...

msnbc.msn.com

Multiple meds needed to stop bird flu pandemic
Governments should stock several drugs to prevent resistance, experts say

Unfortunately, short needle with obese pts screwup not mentioned in clinical failure reference.

...A new influenza drug, peramivir, is being developed by Biocryst Pharmaceuticals Inc but it must be injected and it has not performed well in clinical trials. Two older flu drugs are available but flu viruses have quickly developed resistance to them, although some experts believe they may be useful in cocktails with newer drugs.

...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext